Perla Pucci

Cambridge, ENG CB20QQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Integrated clinical, genomic and functional characterization of a novel ALK variant in neuroblastoma.

Integrated clinical, genomic and functional characterization of a novel ALK variant in neuroblastoma.

Journal: Cancer letters
Published: November 05, 2025

EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines.

EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines.

Journal: Epigenomics
Published: January 29, 2025

The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer.

The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer.

Journal: Molecular cancer
Published: June 24, 2024

REST-dependent glioma progression occurs independently of the repression of the long non-coding RNA HAR1A.

REST-dependent glioma progression occurs independently of the repression of the long non-coding RNA HAR1A.

Journal: PloS one
Published: May 08, 2024

METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma.

METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma.

Journal: The EMBO journal
Published: October 18, 2023

Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Journal: Nature communications
Published: October 28, 2022

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL.

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL.

Journal: Cancers
Published: December 10, 2021

Combination therapy and noncoding RNAs: a new era of cancer personalized medicine.

Combination therapy and noncoding RNAs: a new era of cancer personalized medicine.

Journal: Epigenomics
Published: December 02, 2021

HAR1: an insight into lncRNA genetic evolution.

HAR1: an insight into lncRNA genetic evolution.

Journal: Epigenomics
Published: October 22, 2021

Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.

Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.

Journal: Discover oncology
Published: August 26, 2021

The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers.

The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers.

Journal: International journal of molecular sciences
Published: June 21, 2021

The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells.

The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells.

Journal: Cancers
Published: February 09, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026